The use of stimulants to modify performance during sleep loss: a review by the sleep deprivation and Stimulant Task Force of the American Academy of Sleep Medicine.
Bonnet
Michael H
MH
Dayton Department of Veterans Affairs Medical Center, Wright State University, and Kettering Medical Center, Dayton, OH 45428, USA. bonnetmichael@yahoo.com
Balkin
Thomas J
TJ
Dinges
David F
DF
Roehrs
Timothy
T
Rogers
Naomi L
NL
Wesensten
Nancy J
NJ
D001559:Benzhydryl Compounds / Q000009:adverse effects*; D002110:Caffeine / Q000009:adverse effects*; D000697:Central Nervous System Stimulants / Q000009:adverse effects*; D006801:Humans; D008694:Methamphetamine / Q000009:adverse effects*; D000077408:Modafinil; D012890:Sleep / Q000187:drug effects*; D012892:Sleep Deprivation / Q000139:chemically induced*; D007319:Sleep Initiation and Maintenance Disorders / Q000503:physiopathology*; D013997:Time Factors
D001559:Benzhydryl Compounds; D000697:Central Nervous System Stimulants; D002110:Caffeine; D008694:Methamphetamine; D000077408:Modafinil